38
total announcements
FISCHER.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,975 Cr
P/E (TTM)
12.1
EPS (TTM)
₹2.34
52W Low
₹28.11
52W High
₹121.70
Dividend Yield
0.17%
Beta
0.18
Price / Book
4.7
Debt / Equity
27.7
Revenue (TTM)
₹367 Cr
Gross Margin
34.33%
Operating Margin
12.07%
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has dispatched a Postal Ballot Notice to shareholders for approval of certain related party transactions and increase in borrowing limits.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance of dematerialized securities and listing on stock exchanges.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on October 14, 2026. The Board approved and took on record the Postal Ballot Notice to be issued to Shareholders for obtaining their consent for certain Material Related Party transactions and increase in borrowing limits. The Board also approved the appointment of M/s Nuren Lodaya & Associates Practicing Company Secretary as Scrutinizer for the Postal Ballot.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 29, 2026, and informed the Exchange regarding voting results.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has held its 33rd Annual General Meeting (AGM) through video conferencing on September 29, 2026. The meeting was attended by 61 members, and the requisite quorum was present. The company has complied with various circulars issued by MCA and SEBI, and the AGM was conducted smoothly.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about General Updates, specifically updates on material wholly owned subsidiaries. The subsidiaries declared dividends: Time Medical International Ventures (India) Private Limited declared a dividend of Rs. 6,50,00,000, FlynnCare Health Innovations Private Limited declared a dividend of Rs. 10,00,00,000, and FMV Global Innovation Pte Limited declared an interim dividend of USD 1,100,000.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has issued a corrigendum to its Annual Report FY 2025-26, correcting minor errors and omissions in the report.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding the outcome of its Board Meeting held on September 24, 2026, where the Board approved and took on record the rights issues by its wholly owned subsidiaries, Time Medical International Ventures (India) Private Limited, FlynnCare Health Innovations Private Limited, and FMV Global Innovation Pte. Ltd., and the Company's investment in the equity shares of these subsidiaries.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding 'Presentation of Investor/Analyst meeting' and submitted a revised presentation as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding 'Chairman's Letter to Shareholders', providing an overview of the Company's business, key developments and its outlook.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the dispatch of Notice of Annual General Meeting to shareholders through newspaper advertisements.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about a presentation for an Investor/Analyst call scheduled to be held on September 7, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about Advance Intimation of dispatch of Annual Report 2026 through electronic mode and the Annual General Meeting for 2026 will be conducted through Video Conferencing.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the schedule of their meet with analysts and institutional investors.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors approved and took on record the appointment of Mr. David Yeow as the Additional Independent Director and reconstitution of the Audit Committee.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the outcome of its Board meeting held on 03/09/2026, where it approved the appointment of Mr. David Yeow as the Additional Independent Director and reconstituted the Audit Committee.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced the record date for the purpose of dividend as September 22, 2026, and the register of members and share transfer books will be closed from September 23 to 29, 2026, for the annual general meeting.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Private Ltd., has launched the CLARION 64/128-Slice AI-Driven CT System in India at the India Health Expo 2026.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's step-down subsidiary Time Medical Philippines has been awarded a province-wide digital healthcare project for rollout across Catanduanes Province, deploying an integrated solution combining Health Kiosks with the PhilHealth-accredited FlynnCare Clinic Management System (CMS).